BSE filing, NSE: KPIL. Summary written from the filing by ALFA Finder's alert engine.
Kalpataru Projects International Ltd: key numbers
- Share price
- ₹1,337.70
- Market cap
- ₹22,844 Cr
- Revenue (annual)
- ₹27,143 Cr
- Net profit (annual)
- ₹1,040 Cr
- P/E (TTM)
- 20.1×Sector 32.2×
- Promoter holding
- 33.58%+0.00% QoQ
- FII holding
- 10.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalpataru Projects International Ltd
All →Kalpataru Projects International Board Meeting Date
Kalpataru Projects will hold a board meeting on November 5, 2026 to approve quarterly and half-year results. An investor call follows on November 6, and the trading window stays closed.
Kalpataru Projects International Legal & Regulatory
KPIL received a GST order demanding INR 6.76 Crore penalty for FY 2018-19 and 2020-21. The company plans to appeal before the first Appellate Authority.
- Value
- ₹6.76 Cr
Kalpataru Projects International IPO
Kalpataru's subsidiary Linjemontage's IPO over-allotment option was exercised for 18.8 lakh shares, ending stabilisation. Unexercised shares return to Kalpataru Sweden, leaving its stake at 66.45%.
Kalpataru Projects International Bags ₹2,349 Cr Order
Kalpataru Projects International Limited secured new orders totaling ₹2,349 Crore. These wins include projects in the Power Transmission & Distribution and Buildings & Factories sectors.
- Value
- ₹2,349 Cr
Kalpataru Projects International Other Announcement
The company has filed its quarterly shareholding pattern statement for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Kalpataru Projects International Legal & Regulatory
Kalpataru Projects reported a partially successful appeal against a GST tax order. The penalty has been reduced to ₹0.14 Crore from the previous amount.
- Value
- ₹0.14 Cr
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr